| | |
|---|
| ASPsiRNA information |
siRNA Id: | aspsirna0999
|
|
siRNA Name: | HAT DsRNA
|
| Mismatch information |
Wild siRNA (As strand 3'->5'): | CACGUCGCCGCCGCGCCGCGC
|
|
ASP-siRNA (As strand 3'->5'): | CACGCCGCCGCCGCGCCGCGC
|
|
Mismatch position in siRNA: | C17U |
| Gene Information |
Gene Name | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1(CITED1) |
|
Target Sequence (5'->3'): | GGCACTGTGCGGUGCAGCGGCGGCGCGGCGCGGTGCGGG
|
|
Wild allele (5'->3'): | GUGCAGCGGCGGCGCGGCGCG
|
|
Mutant allele (5'->3'): | GUGCGGCGGCGGCGCGGCGCG
|
|
Position of siRNA on target gene: | 306-326
|
| Respective Gene/Protein Resources |
GenBank Accession: | NM_004143.3 |
| Cytogenic location: | Xq13.1 |
| Chromosomal coordinates: | X:71,521,487-71,527,036 |
| UniProt ID: | P34545 |
| HUGO ID: | 1546 |
|
Reference SNp(RefSNP): | NA |
| Disease/Mutation information |
Target Mutation: | c.211A>G
|
|
Matation type/variant: | NA
|
|
Mutation at gene level: | NA
|
|
Pathogenic status of mutation: | Pathogenic
|
|
Disease: | Cancer |
| Clinical Resources |
ClinVar ID: | NA |
|
KEGG disease ID: | H00001 |
|
OMIM ID: | 600140 |
|
COSMIC: | CITED1 |
|
DECIPHER: | CITED1 |
|
GeneTests: | CITED1 |
| ASP siRNA details |
Mutant allele (5'->3'): | GUGCGGCGGCGGCGCGGCGCG
|
|
ASP-siRNA (As strand 3'->5'): | CACGCCGCCGCCGCGCCGCGC
|
|
Percentage efficacy of ASP-siRNA for mutant allele: | 68
|
|
Wild allele (5'->3'): | GUGCAGCGGCGGCGCGGCGCG
|
|
ASP-siRNA (As strand 3'->5'): | CACGCCGCCGCCGCGCCGCGC
|
|
Percentage efficacy of ASP-siRNA for wild allele: | 38
|
|
Relative difference: | 30
|
| Wild siRNA details |
Wild allele (5'->3'): | GUGCAGCGGCGGCGCGGCGCG
|
|
Wild siRNA (As strand 3'->5'): | CACGUCGCCGCCGCGCCGCGC
|
|
Percentage efficacy of wild siRNA for wild allele: | Lowest effective
|
|
Wild allele (5'->3'): | GUGCAGCGGCGGCGCGGCGCG
|
|
ASP-siRNA (As strand 3'->5'): | CACGCCGCCGCCGCGCCGCGC
|
|
Percentage efficacy of Wild sirna for mutant allele: | 68
|
|
Relative difference : | Poor discrimination
|
| General information |
Mismatch incorporated in siRNA/Target: | siRNA
|
| Cell-line used: | N2 wild-type worms (C.Elegans) |
| Experimental technique used: | Western blot |
| Transfection method: | Lipofectamine 2000 |
| siRNA expression method: | Promega |
| Post-transfection duration: | 24 hours |
| Concentration used: | 10mM |
| Reference: | 11751575 |
| Delivery method: | Transfection |
| Article title: | HAT activity is essential for CBP-1-dependent transcription and differentiation in Caenorhabditis elegans. |
| Authors: | Victor M, Bei Y, Gay F, Calvo D, Mello C, Shi Y. |
| Journal Reference: | EMBO Rep. 2002 Jan;3(1):50-5. Epub 2001 Dec 19. |
